Microbiome health company Biome Australia announced an optimistic revenue forecast for the first quarter of FY25.
The company expects sales revenue to exceed $4 million, surpassing the previous record of $3.8 million set in the fourth quarter of FY24.
"We're excited to see such a strong start to the September quarter, reinforcing our commitment to improving health outcomes through innovative biotherapeutics," said a company spokesperson.
The recent development marks another milestone for the Australia-based company that specialises in developing and commercialising evidence-based live biotherapeutics and complementary medicines, such as the Activated Probiotics range.
The products are supported by extensive clinical research and are designed to manage various health concerns including low mood and iron malabsorption.
Biome Australia, incorporated in 2018, distributes its products both locally and internationally, collaborating with leading organisations in microbiome research and development to offer unique probiotic solutions with enhanced stability and efficacy.
Approved by Biome Australia's board of directors, the announcement reflects the company's robust business strategies and its ongoing mission to provide accessible, natural medicines backed by scientific evidence.
Biome Australia is a microbiome health company that develops, licenses, commercialises and markets evidence-based live biotherapeutics (probiotics) and complementary medicines.
It develops, manufactures, and distributes evidence-based products linking the gut and human health through company-owned brands, such as Activated Nutrients and Activated Probiotics. Activated Nutrients offers a range of completely organic, plant-based, all-in-one nutritional products.